Alisha Sud is Director of Policy at the Association for Accessible Medicines. Alisha is responsible for collaborating with leadership to identify and respond to key policy issues affecting AAM members. She also manages research initiatives, public comments, policy papers, and other materials that advance the strategic goals and mission of AAM.
Prior to joining AAM, Alisha was Associate Director of FasterCures, a center of the Milken Institute focused on creating a patient-centered system that accelerates science research, dismantles barriers to access, and connects patients with treatments. Alisha previously worked at global strategic advisory and commercial diplomacy firm Albright Stonebridge Group.
Alisha has extensive experience working with public and private stakeholders to advance global and domestic health policy initiatives. Alisha received her Bachelor of Arts from the University of Vermont with a degree in International Development and a certificate in International Studies from the Johns Hopkins University School of Advanced International Studies. Alisha is currently a Master of Public Health candidate at the Bloomberg School of Public Health.